BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a developer of DNA-based vaccines against cancer and infectious diseases, announced today that the company will highlight its DNA vaccines and electroporation delivery technology at the annual meeting of the American Society of Gene & Cell Therapy on May 20-22 at the Washington Marriott Wardman Park in Washington, DC. Several of Inovio’s scientists and collaborators will make podium presentations:
